Glycolysis regulates the expansion of myeloid-derived suppressor cells in tumor-bearing hosts through prevention of ROS-mediated apoptosis.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28492541)

Published in Cell Death Dis on May 11, 2017

Authors

Shiou-Ling Jian1, Wei-Wei Chen1, Yu-Chia Su2, Yu-Wen Su3, Tsung-Hsien Chuang3, Shu-Ching Hsu4, Li-Rung Huang1

Author Affiliations

1: Institute of Molecular and Genomic Medicine, National Health Research Institutes, Miaoli, Taiwan.
2: National Laboratory Animal Center, National Applied Research Laboratories, Taipei, Taiwan.
3: Immunology Research Center, National Health Research Institutes, Miaoli, Taiwan.
4: National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli, Taiwan.

Articles cited by this

Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27

Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol (2009) 25.96

NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol (2004) 12.93

Coordinated regulation of myeloid cells by tumours. Nat Rev Immunol (2012) 12.19

Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab. J Clin Oncol (2014) 9.86

Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial. Lancet (2014) 8.63

Posttranscriptional control of T cell effector function by aerobic glycolysis. Cell (2013) 6.30

Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis (2000) 5.78

Fuel feeds function: energy metabolism and the T-cell response. Nat Rev Immunol (2005) 5.29

Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation. Blood (2010) 3.98

Revving the engine: signal transduction fuels T cell activation. Immunity (2007) 3.57

All-trans-retinoic acid eliminates immature myeloid cells from tumor-bearing mice and improves the effect of vaccination. Cancer Res (2003) 3.45

Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells. J Immunol (2010) 3.38

Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells. J Immunol (2009) 3.23

Metabolic pathways in immune cell activation and quiescence. Immunity (2013) 3.09

Triggering and modulation of apoptosis by oxidative stress. Free Radic Biol Med (2000) 2.98

Energy metabolism of human neutrophils during phagocytosis. J Clin Invest (1982) 2.37

A syndrome with congenital neutropenia and mutations in G6PC3. N Engl J Med (2009) 2.30

IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis. Nature (2015) 2.04

CpG blocks immunosuppression by myeloid-derived suppressor cells in tumor-bearing mice. Clin Cancer Res (2011) 1.89

Peculiarities of cell death mechanisms in neutrophils. Cell Death Differ (2011) 1.64

Metabolic reprogramming in macrophages and dendritic cells in innate immunity. Cell Res (2015) 1.53

TNF signaling drives myeloid-derived suppressor cell accumulation. J Clin Invest (2012) 1.52

Myeloid-derived suppressor cells express the death receptor Fas and apoptose in response to T cell-expressed FasL. Blood (2011) 1.47

Increased recurrence and metastasis in patients whose primary head and neck squamous cell carcinomas secreted granulocyte-macrophage colony-stimulating factor and contained CD34+ natural suppressor cells. Int J Cancer (1997) 1.46

Metabolic shifts in immunity and inflammation. J Immunol (2010) 1.45

Therapeutic regulation of myeloid-derived suppressor cells and immune response to cancer vaccine in patients with extensive stage small cell lung cancer. Cancer Immunol Immunother (2013) 1.43

Reactive oxygen species limit neutrophil life span by activating death receptor signaling. Blood (2004) 1.30

ER stress regulates myeloid-derived suppressor cell fate through TRAIL-R-mediated apoptosis. J Clin Invest (2014) 1.16

Neutrophil stress and apoptosis underlie myeloid dysfunction in glycogen storage disease type Ib. Blood (2008) 1.11

Isolation, culture and analysis of mouse mammary epithelial cells. Methods Mol Biol (2010) 1.07

Apoptotic neutrophils in the circulation of patients with glycogen storage disease type 1b (GSD1b). Blood (2003) 1.06

Myeloid-derived suppressor cells in breast cancer. Breast Cancer Res Treat (2013) 1.04

Inflammatory neutrophils retain susceptibility to apoptosis mediated via the Fas death receptor. J Leukoc Biol (2000) 1.02

Assessing serum cytokine profiles in breast cancer patients receiving a HER2/neu vaccine using Luminex technology. Oncol Rep (2007) 1.02

Lack of glucose recycling between endoplasmic reticulum and cytoplasm underlies cellular dysfunction in glucose-6-phosphatase-beta-deficient neutrophils in a congenital neutropenia syndrome. Blood (2010) 0.96

Breast Cancer Cell-Derived GM-CSF Licenses Regulatory Th2 Induction by Plasmacytoid Predendritic Cells in Aggressive Disease Subtypes. Cancer Res (2015) 0.83

Phosphoenolpyruvate, a glycolytic intermediate, as a cytoprotectant and antioxidant in ex-vivo cold-preserved mouse liver: a potential application for organ preservation. J Pharm Pharmacol (2012) 0.81